These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38924813)

  • 21. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability.
    Solar-Cafaggi D; Marino L; Uribe-Uribe N; Morales-Buenrostro LE
    Transpl Immunol; 2018 Dec; 51():40-44. PubMed ID: 30170180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients.
    Pongpirul W; Chancharoenthana W; Pongpirul K; Leelahavanichkul A; Kittikowit W; Jutivorakool K; Nonthasoot B; Avihingsanon Y; Eiam-Ong S; Praditpornsilpa K; Townamchai N
    Nephrology (Carlton); 2018 Feb; 23(2):169-174. PubMed ID: 27888573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term kidney allograft survival in patients with transplant glomerulitis.
    Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
    Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Machine learning-supported interpretation of kidney graft elementary lesions in combination with clinical data.
    Labriffe M; Woillard JB; Gwinner W; Braesen JH; Anglicheau D; Rabant M; Koshy P; Naesens M; Marquet P
    Am J Transplant; 2022 Dec; 22(12):2821-2833. PubMed ID: 36062389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction.
    Gimeno J; Redondo D; Pérez-Sáez MJ; Naranjo-Hans D; Pascual J; Crespo M
    Nephrol Dial Transplant; 2016 Nov; 31(11):1938-1946. PubMed ID: 27312147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification: Surveillance by 1-year protocol biopsies for kidney transplantation.
    Nakagawa K; Tsuchimoto A; Ueki K; Matsukuma Y; Okabe Y; Masutani K; Unagami K; Kakuta Y; Okumi M; Nakamura M; Nakano T; Tanabe K; Kitazono T;
    Am J Transplant; 2021 Jan; 21(1):174-185. PubMed ID: 32484280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
    Crespo E; Roedder S; Sigdel T; Hsieh SC; Luque S; Cruzado JM; Tran TQ; Grinyó JM; Sarwal MM; Bestard O
    Transplantation; 2017 Jun; 101(6):1400-1409. PubMed ID: 27362314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas.
    Halloran PF; Matas A; Kasiske BL; Madill-Thomsen KS; Mackova M; Famulski KS
    Am J Transplant; 2019 May; 19(5):1356-1370. PubMed ID: 30417539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples.
    Christakoudi S; Runglall M; Mobillo P; Tsui TL; Duff C; Domingo-Vila C; Kamra Y; Delaney F; Montero R; Spiridou A; Kassimatis T; Phin-Kon S; Tucker B; Farmer C; Strom TB; Lord GM; Rebollo-Mesa I; Stahl D; Sacks S; Hernandez-Fuentes MP; Chowdhury P
    EBioMedicine; 2019 Mar; 41():571-583. PubMed ID: 30833191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study.
    Halloran PF; Reeve J; Akalin E; Aubert O; Bohmig GA; Brennan D; Bromberg J; Einecke G; Eskandary F; Gosset C; Duong Van Huyen JP; Gupta G; Lefaucheur C; Malone A; Mannon RB; Seron D; Sellares J; Weir M; Loupy A
    Am J Transplant; 2017 Nov; 17(11):2851-2862. PubMed ID: 28449409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells.
    Matz M; Lorkowski C; Fabritius K; Wu K; Rudolph B; Frischbutter S; Brakemeier S; Gaedeke J; Neumayer HH; Mashreghi MF; Budde K
    Transpl Immunol; 2016 Nov; 39():18-24. PubMed ID: 27693310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of novel biomarkers for acute kidney transplant rejection using DIA-MS based proteomics.
    Wang C; Feng G; Zhao J; Xu Y; Li Y; Wang L; Wang M; Liu M; Wang Y; Mu H; Zhou C
    Proteomics Clin Appl; 2024 May; 18(3):e2300047. PubMed ID: 38215274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary metabolomics for noninvasive detection of borderline and acute T cell-mediated rejection in children after kidney transplantation.
    Blydt-Hansen TD; Sharma A; Gibson IW; Mandal R; Wishart DS
    Am J Transplant; 2014 Oct; 14(10):2339-49. PubMed ID: 25138024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulation of interferon type I pathway-related genes RSAD2 and ETV7 specifically indicates antibody-mediated rejection after kidney transplantation.
    Matz M; Heinrich F; Zhang Q; Lorkowski C; Seelow E; Wu K; Lachmann N; Addo RK; Durek P; Mashreghi MF; Budde K
    Clin Transplant; 2018 Dec; 32(12):e13429. PubMed ID: 30341925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free microRNA levels in plasma distinguish T-cell mediated rejection from stable graft function after kidney transplantation.
    Matz M; Lorkowski C; Fabritius K; Durek P; Wu K; Rudolph B; Neumayer HH; Mashreghi MF; Budde K
    Transpl Immunol; 2016 Nov; 39():52-59. PubMed ID: 27663089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum IL-6 predicts risk of kidney transplant failure independently of immunological risk.
    Friedmann J; Schuster A; Reichelt-Wurm S; Banas B; Bergler T; Steines L
    Transpl Immunol; 2024 Jun; 84():102043. PubMed ID: 38548029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular assessment of disease states in kidney transplant biopsy samples.
    Halloran PF; Famulski KS; Reeve J
    Nat Rev Nephrol; 2016 Sep; 12(9):534-48. PubMed ID: 27345248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
    Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.